ClinicalThought

Share

Program Content

Activities

  • Ibrutinib + Rituximab
    Ibrutinib Plus Rituximab and the Expanding Therapeutic Toolbox for Previously Untreated CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 26, 2020

    Expires: June 25, 2021

  • CLL: Expert Perspectives
    Expert Perspectives on Key New Evidence in CLL Therapy
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

Faculty

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company

Partners

CLL Society

ProCE Banner